title: Estimation of parameters for the elimination of an orally administered test substance with unknown absorption.
abstract: Assessment of the elimination of an oral test dose based on plasma concentration values requires correction for the effect of gastric release and absorption. Irregular uptake processes should be described 'model independently', which requires estimation of a large number of absorption parameters. To limit the associated computational effort a new approach is developed with a reduced number of unknown parameters. A marginalized and regularized absorption approach (MRA) is defined, which uses for the uptake just one parameter to control rigidity of the uptake curve. For validation, elimination and absorption were reproduced using published IVIVC data and a synthetic data set for comparison with approaches using a 'model-free'--staircase function or mechanistic models to describe absorption. MRA performed almost as accurate as well specified mechanistic models, which gave the best reproduction. MRA demonstrated a 50fold increase in computational efficiency compared to other approaches. The absorption estimated for the IVIVC study demonstrated an in vivo-in vitro correlation comparable to published values. The newly developed MRA approach can be used to efficiently and accurately estimate elimination and absorption with a restricted number of adaptive parameters and with automatic adjustment of the complexity of the uptake.
authors: Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätklinikum für Anästhesiologie, Helmholtzstr. 8/1, 89081, Ulm, Germany. josef.vogt@uni-ulm.de
authors: Josef A
authors: JA
authors: Vogt
authors: Christian
authors: C
authors: Denzer
mesh_terms: D000042:Absorption; D000284:Administration, Oral; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010599:Pharmacokinetics
chemical_list: D004364:Pharmaceutical Preparations
references: J Pharmacokinet Biopharm. 1995 Dec;23(6):581-610
references: 8733948
references: J Pharmacokinet Biopharm. 1986 Apr;14(2):213-25
references: 3746639
references: J Pharm Sci. 1983 Oct;72(10):1103-27
references: 6358460
references: J Pharm Sci. 2005 Sep;94(9):1949-56
references: 16052544
references: J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):711-26
references: 17653836
references: Pharm Res. 2005 Aug;22(8):1227-35
references: 16078132
references: J Pharmacokinet Pharmacodyn. 2001 Apr;28(2):109-28
references: 11381566
references: J Pharmacokinet Biopharm. 1995 Dec;23(6):651-72
references: 8733951
references: J Pharmacokinet Biopharm. 1997 Oct;25(5):615-42
references: 9679225
references: Int J Pharm. 1999 Sep 20;186(2):119-25
references: 10486429
references: J Math Biol. 1984;20(1):95-102
references: 6491545
references: J Pharmacokinet Biopharm. 1995 Jun;23(3):267-86
references: 8834196
references: J Pharmacokinet Biopharm. 1997 Jun;25(3):277-312
references: 9474530
references: Biopharm Drug Dispos. 1994 Jan;15(1):75-86
references: 8161718
references: J Clin Pharmacol. 2003 Mar;43(3):211-27
references: 12638389